Bioatla Inc
BCAB
NASDAQ
Biotechnology
$3.09
USD
-0.36 (-10.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $5.73M
Volume 143.7K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
LABT | Lakewood-Amedex Biotherapeutics Inc | - | - | - | - | |
DRMA | Dermata Therapeutics Inc | $6.31M | - | - | - | |
BCAB | Bioatla Inc | $5.73M | - | -81.8% | - | |
GOVX | GeoVax Labs Inc | $5.31M | - | - | - | |
APVO | Aptevo Therapeutics Inc | $5.16M | - | - | - | |
TCRT | Alaunos Therapeutics Inc | $4.86M | - | -70.0% | - | |
HCWB | HCW Biologics Inc | $4.67M | - | -98.7% | - | |
MBIO | Mustang Bio Inc | $4.53M | - | - | - | |
MBRX | Moleculin Biotech Inc | $3.93M | - | - | - |
Top Peer by Growth
GeoVax Labs Inc
+6.4% YoY Revenue
Best 1-Year Return
Alaunos Therapeutics Inc
-16.7% Return